Recruiting Myeloproliferative Neoplasms Studies in Indianapolis
About Myeloproliferative Neoplasms Clinical Trials in Indianapolis
Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.
There are currently 1 myeloproliferative neoplasms clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 460 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myeloproliferative Neoplasms Clinical Trials in Indianapolis — FAQ
Are there myeloproliferative neoplasms clinical trials in Indianapolis?
Yes, there are 1 myeloproliferative neoplasms clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Indianapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.
Are clinical trials in Indianapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.
What myeloproliferative neoplasms treatments are being tested?
The 1 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.
Data updated October 12, 2026 from ClinicalTrials.gov